Press Releases for RX

Press Releases
IMS Health to Launch Oncology Quantifier, Delivering Integrated Insights for Enhanced Market Measurement, Commercial Strategies
PicksThatMove.com Announces Investment Opinion On: IMS Health Inc, MetLife Inc., ON Semiconductor Corporation, Neohydro Technologies Corporation and WesternZagros Resources Ltd.
IMS Health to be Acquired by TPG and CPP Investment Board
IMS Health Exploring Strategic Alternatives
RidgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on AEG, ETR, LFC, RX, ARG and TD
IMS Health Launches ˜Ask IMS' to Help Early-Stage Biopharmaceutical Companies Enhance Business Development, Commercialization Strategies
IMS Appoints Don Otterbein General Manager, Business Transformation Services, to Lead Expanded Knowledge Process Outsourcing Initiative
IMS Named to Dow Jones Sustainability North America Index
Lilly moves on from Prozac to Cymbalta
BenchmarkJournal.Com Free Analyst Review for A, COG, SVU, DF, RX and AMR
Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance
Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results and Operational Highlights
IMS Launches Global Message IQ, Offering Instant Access to Promotional Message Effectiveness Research
Cooper Elected to Teradata Board of Directors
IMS Health Announces 2009 Second-Quarter Results and Comprehensive Restructuring Plan to Improve Profitability
IMS Sets Third-Quarter 2009 Dividend
IMS Health to Announce Second-Quarter 2009 Results, Conduct Analyst Conference Call on July 23
IMS Names Kimberly Gray Chief Privacy Officer, Americas
150-Year-Old Dohmen Company Names First Female CEO
wRatings and UTEK Corporation's Strategos Identify Most Competitive Health Care Companies
wRatings and UTEK Corporation’s Strategos Identify Most Competitive Health Care Companies
wRatings and UTEK Corporation's Strategos Identify Most Competitive Health Care Companies
IMS to Present at the William Blair Growth Stock Conference on June 10 at 2:00 p.m. CT
IMS to Present at Goldman Sachs Global Healthcare Conference on June 9 at 3:45 p.m. ET
Warner Chilcott Reports Operating Results for the Quarter Ended March 31, 2009 and Updates 2009 Full Year Guidance - May 11 2009 11:55AM
Warner Chilcott Reports Operating Results for the Quarter Ended March 31, 2009 and Updates 2009 Full Year Guidance - May 11 2009 7:57AM
Photos: Generic Pharmaceuticals Saved $734 Billion Over Last Decade
IMS to Present at Bank of America and Merrill Lynch Health Care Conference on May 14 at 8:00 a.m. ET
IMS to Present at the Robert W. Baird & Co. 2009 Growth Stock Conference on May 13 at 1:20 p.m. CT
Notice of the Annual Meeting of Stockholders of EpiCept Corporation - Apr 30 2009 12:55AM
IMS Health Reports 2009 First-Quarter Results
IMS Sets Second-Quarter 2009 Dividend
IMS Health to Announce First-Quarter 2009 Results, Conduct Analyst Conference Call on April 23
IMS, SDI Seek U.S. Supreme Court Review in Critical First Amendment Case
Bradley Sheares Elected to IMS Health Board of Directors
IMS to Present at Raymond James Institutional Investors Conference on March 11 at 9:15 a.m. ET
IMS to Present at Barclays Capital Global Healthcare Conference on March 10 at 11:15 a.m. ET
IMS Sets First-Quarter 2009 Dividend
IMS to Present at UBS Global Healthcare Services Conference on February 11 at 9:30 a.m. ET
IMS Health Reports 2008 Fourth-Quarter and Full-Year Results
IMS Health to Announce Fourth-Quarter and Full-Year 2008 Results, Conduct Analyst Conference Call on February 5
IMS to Present at J.P. Morgan Healthcare Conference on January 12 at 2:30 p.m. PST
New Report Highlights Dramatic Change in U.S. Drug Spending Trends, Policy Implications
New Study Highlights Rising Number of Type 2 Diabetes Patients in U.S., Increasing Complexity of Treatments
IMS to Present at Credit Suisse Conference on November 12 at 10:30 a.m. MST
IMS Health Forecasts 4.5 - 5.5 Percent Growth for Global Pharmaceutical Market in 2009, Exceeding $820 Billion
IMS Health Delivers Double-Digit Net Income and EPS Growth In Third Quarter; Revenue Up 6 Percent
IMS Sets Fourth-Quarter 2008 Dividend
IMS Health to Announce Third-Quarter Results, Conduct Analyst Conference Call on October 23
IMS to Present at UBS Conference On September 24 at 12:30 p.m. ET
IMS to Present at Thomas Weisel Partners Conference on September 4 at 9:10 a.m. ET
IMS Sets Global Standard for Patient-Centered Metrics
IMS Health Delivers 12 Percent Revenue and 11 Percent Operating Income Growth in Second Quarter
IMS Sets Third-Quarter 2008 Dividend
IMS Health to Announce Second-Quarter Results, Conduct Analyst Conference Call on July 21
IMS Health Reports Global Biotech Sales Grew 12.5 Percent in 2007, Exceeding $75 Billion
IMS to Present at William Blair Growth Stock Conference on June 17 at 1:40 p.m. CDT
IMS to Present at Goldman Sachs Global Healthcare Conference on June 10 at 2:40 p.m. PT
IMS to Present at FBR Capital Markets Conference on May 28 at 12:50 p.m. ET - May 26 2008 10:30PM
IMS Health Forecasts Continued Double-Digit Annual Growth of Cancer Therapeutics: Global Sales Expected to Exceed $75 Billion by 2012 - Jun 2 2008 2:55AM
IMS to Present at Bank of America Health Care Conference on May 14 at 4:00 p.m. PT - Jun 2 2008 2:55AM
IMS to Present at Robert W. Baird Growth Stock Conference on May 13 at 8:20 a.m. CDT - Jun 2 2008 2:55AM
IMS to Present at Morgan Stanley Global Healthcare Conference on May 1 at 3:00 p.m. ET
IMS and Leading Public Health Professionals Announce Consortium for Healthcare Research and Collaboration
IMS Health Delivers 13 Percent Revenue Growth in First Quarter
IMS Sets Second-Quarter 2008 Dividend
IMS Health to Announce First-Quarter Results, Conduct Analyst Conference Call on April 17
Wall Street News Alert: Stock Watch Issued on ERUG! July 21, 2005